Epidemiology : 1st described
in 1946 as the pathogenic agent causing pharyngitis and cutaneous infections
among US servicemen and indigenous peoples of the South Pacific in 1946.
As a result of its close resemblance to
Corynebacterium pyogenes,
some investigators believed the bacterium to be a mutant of this species
and appended a subspecies name,
C. pyogenes subsp. hominis. Based
on its biochemical and nucleic acid characteristics, the bacterium was
renamed and reclassified as the 1st member of the genus
Arcanobacterium,
which means secretive bacteria, in 1982. In 2005 an antibiotics-resistant
strain was found in 142 students with cold symptoms in Guri, Gyeonggi province,
South Korea, starting on 20 May 2005
Transmission : spread through an unknown
route by human contact with people who are infected. The chronic carrier
state appears to be rare
=> primarily causing an exudative
pharyngitis
with a rash that may look like scarlet fever, the spectrum of diseases
caused by
A. haemolyticum has been expanded to include invasive
infections, including sepsis and osteomyelitis. The pathophysiology of
the rash is unknown;
however, it is thought that the rash is caused by a bacterial exotoxin.
Therapy : despite being fully sensitive
to penicillin
in vitro, penicillin treatment failures of
A. haemolyticum
were frequent
ref.
The ability of
A. haemolyticum to survive intracellularly for 4
days, thus creating intracellular reservoirs of bacteria, might explain
this dichotomy. Osterlund also showed that erythromycin, an antibiotic
known to penetrate well intracellularly, efficiently killed these bacteria